Responding to an announcment by the UK Government to fund £30million to help fight global antimicrobial resistance (AMR), Dr Sheuli Porkess, Deputy Chief Scientific Officer, said:
“The commitment by the UK Government to fund £30million to help fight antimicrobial resistance (AMR) is great news and an example of the kind of partnerships we need if we are to successfully tackle this global issue. Detecting, preventing and controlling AMR requires a coordinated and sustained response between Government, the NHS and industry to deliver results.
“The UK pharmaceutical industry is already at the forefront of a global movement to address antimicrobial resistance. There are currently 34 antibiotics and infection-preventing vaccines in development but there is an urgent need to scale up this research.
“We look forward to continuing to work with Government to ensure the UK takes the global lead in tackling AMR.”